Free Trial

Kestra Medical Technologies (KMTS) Competitors

Kestra Medical Technologies logo
$20.45 +1.63 (+8.66%)
Closing price 04:00 PM Eastern
Extended Trading
$20.52 +0.07 (+0.32%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KMTS vs. LIVN, NVST, IRTC, MMED, and WRBY

Should you buy Kestra Medical Technologies stock or one of its competitors? MarketBeat compares Kestra Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kestra Medical Technologies include LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), MiniMed Group (MMED), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

How does Kestra Medical Technologies compare to LivaNova?

Kestra Medical Technologies (NASDAQ:KMTS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

In the previous week, Kestra Medical Technologies had 2 more articles in the media than LivaNova. MarketBeat recorded 2 mentions for Kestra Medical Technologies and 0 mentions for LivaNova. LivaNova's average media sentiment score of 1.87 beat Kestra Medical Technologies' score of 0.39 indicating that LivaNova is being referred to more favorably in the news media.

Company Overall Sentiment
Kestra Medical Technologies Neutral
LivaNova Very Positive

Kestra Medical Technologies has higher earnings, but lower revenue than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$59.81M19.96-$113.81M-$3.96N/A
LivaNova$1.39B2.92-$242.47M$1.9537.81

97.6% of LivaNova shares are held by institutional investors. 3.6% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Kestra Medical Technologies currently has a consensus target price of $27.40, indicating a potential upside of 33.99%. LivaNova has a consensus target price of $79.38, indicating a potential upside of 7.67%. Given Kestra Medical Technologies' higher probable upside, research analysts plainly believe Kestra Medical Technologies is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
LivaNova
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67

LivaNova has a net margin of 7.48% compared to Kestra Medical Technologies' net margin of -171.87%. LivaNova's return on equity of 16.48% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-171.87% -65.49% -46.39%
LivaNova 7.48%16.48%7.59%

Kestra Medical Technologies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

LivaNova beats Kestra Medical Technologies on 11 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Envista?

Envista (NYSE:NVST) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

Envista has a net margin of 2.41% compared to Kestra Medical Technologies' net margin of -171.87%. Envista's return on equity of 7.11% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Kestra Medical Technologies -171.87%-65.49%-46.39%

Envista currently has a consensus price target of $28.83, indicating a potential upside of 26.28%. Kestra Medical Technologies has a consensus price target of $27.40, indicating a potential upside of 33.99%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Kestra Medical Technologies had 2 more articles in the media than Envista. MarketBeat recorded 2 mentions for Kestra Medical Technologies and 0 mentions for Envista. Envista's average media sentiment score of 1.00 beat Kestra Medical Technologies' score of 0.39 indicating that Envista is being referred to more favorably in the media.

Company Overall Sentiment
Envista Positive
Kestra Medical Technologies Neutral

Envista has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

Envista has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.37$47M$0.4155.69
Kestra Medical Technologies$59.81M19.96-$113.81M-$3.96N/A

Summary

Envista beats Kestra Medical Technologies on 10 of the 13 factors compared between the two stocks.

How does Kestra Medical Technologies compare to iRhythm Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

In the previous week, iRhythm Technologies had 1 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 3 mentions for iRhythm Technologies and 2 mentions for Kestra Medical Technologies. iRhythm Technologies' average media sentiment score of 0.79 beat Kestra Medical Technologies' score of 0.39 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
iRhythm Technologies
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Kestra Medical Technologies currently has a consensus target price of $27.40, indicating a potential upside of 33.99%. iRhythm Technologies has a consensus target price of $189.69, indicating a potential upside of 76.70%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

iRhythm Technologies has higher revenue and earnings than Kestra Medical Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$59.81M19.96-$113.81M-$3.96N/A
iRhythm Technologies$747.14M4.72-$44.55M-$0.86N/A

Kestra Medical Technologies has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market.

iRhythm Technologies has a net margin of -3.53% compared to Kestra Medical Technologies' net margin of -171.87%. iRhythm Technologies' return on equity of -10.26% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-171.87% -65.49% -46.39%
iRhythm Technologies -3.53%-10.26%-1.39%

Summary

iRhythm Technologies beats Kestra Medical Technologies on 13 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

19.7% of MiniMed Group shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

MiniMed Group has higher revenue and earnings than Kestra Medical Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$2.99B1.32N/AN/AN/A
Kestra Medical Technologies$59.81M19.96-$113.81M-$3.96N/A

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -171.87%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Kestra Medical Technologies -171.87%-65.49%-46.39%

MiniMed Group currently has a consensus price target of $21.33, indicating a potential upside of 51.73%. Kestra Medical Technologies has a consensus price target of $27.40, indicating a potential upside of 33.99%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities analysts plainly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.73
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, MiniMed Group had 8 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 10 mentions for MiniMed Group and 2 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.39 beat MiniMed Group's score of -0.04 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kestra Medical Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

MiniMed Group beats Kestra Medical Technologies on 9 of the 12 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Warby Parker?

Kestra Medical Technologies (NASDAQ:KMTS) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Kestra Medical Technologies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market.

In the previous week, Kestra Medical Technologies had 1 more articles in the media than Warby Parker. MarketBeat recorded 2 mentions for Kestra Medical Technologies and 1 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.18 beat Kestra Medical Technologies' score of 0.39 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Warby Parker
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$59.81M19.96-$113.81M-$3.96N/A
Warby Parker$871.91M2.97$1.64M$0.021,209.25

Kestra Medical Technologies currently has a consensus target price of $27.40, suggesting a potential upside of 33.99%. Warby Parker has a consensus target price of $29.50, suggesting a potential upside of 21.98%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

93.2% of Warby Parker shares are held by institutional investors. 3.6% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to Kestra Medical Technologies' net margin of -171.87%. Warby Parker's return on equity of 2.30% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-171.87% -65.49% -46.39%
Warby Parker 0.15%2.30%1.18%

Summary

Warby Parker beats Kestra Medical Technologies on 13 of the 16 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KMTS vs. The Competition

MetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.10B$8.14B$6.30B$12.43B
Dividend YieldN/A2.60%2.69%5.33%
P/E Ratio-5.1615.6724.0324.35
Price / Sales19.966.47518.85114.60
Price / CashN/A17.0041.3955.53
Price / Book5.113.639.986.72
Net Income-$113.81M$224.05M$3.56B$337.03M
7 Day Performance-3.76%0.30%-0.89%0.09%
1 Month PerformanceN/AN/AN/A-1.78%
1 Year Performance3.34%2.90%28.76%33.98%

Kestra Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KMTS
Kestra Medical Technologies
2.314 of 5 stars
$20.45
+8.7%
$27.40
+34.0%
-4.1%$1.10B$59.81MN/A300
LIVN
LivaNova
3.2513 of 5 stars
$73.80
+1.0%
$79.38
+7.6%
+61.6%$4.01B$1.43B37.853,300
NVST
Envista
4.0891 of 5 stars
$23.59
-0.4%
$28.83
+22.3%
+19.5%$3.85B$2.81B57.5312,000
IRTC
iRhythm Technologies
4.0733 of 5 stars
$113.90
-1.5%
$191.85
+68.4%
-27.9%$3.80B$787.85MN/A2,400
MMED
MiniMed Group
3.4631 of 5 stars
$12.04
+4.6%
$21.67
+80.0%
N/A$3.38B$2.99BN/A8,000

Related Companies and Tools


This page (NASDAQ:KMTS) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners